ISSN: 1744-6872

Journal Home

Journal Guideline

Pharmacogenetics and Genomics Q2 Unclaimed

Lippincott Williams and Wilkins Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmacogenetics and Genomics is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 140. It has an SJR impact factor of 0,579 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,579.

Pharmacogenetics and Genomics focuses its scope in these topics and keywords: cypa, genes, variation, cypc, nicotine, european, variants, therapy, pathway, response, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2) Genetics (Q3) Molecular Biology (Q3) Molecular Medicine (Q3) Genetics (clinical) (Q4) Genetics (clinical) (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,579

SJR Impact factor

140

H Index

30

Total Docs (Last Year)

134

Total Docs (3 years)

1138

Total Refs

336

Total Cites (3 years)

123

Citable Docs (3 years)

1,55

Cites/Doc (2 years)

37,93

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids Q2
Molecular Brain Q2
Biochimica et Biophysica Acta - Molecular Cell Research Q2
Molecular and Cellular Neurosciences Q2
Journal of Developmental Biology Q2

Compare this journals

Aims and Scope

Best articles by citations

Selective serotonin reuptake inhibitors pathway

Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines

The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting beta1 adrenergic receptor antagonist esmolol in healthy individuals

Comment on Xie et al.

Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols

Disposition kinetics and metabolism of nicotine and cotinine in African American smokers

Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment

Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes

The influence of human GSTZ1 gene haplotype variations on GSTZ1 expression

Methodological quality in pharmacogenetic studies with binary assessment of treatment response

Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men

Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitors

SHOW MORE ARTICLES

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene.

Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid

A pharmacogene database enhanced by the 1000 Genomes Project

SiRNA gene therapy using albumin as a carrier

A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy

The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate

CYP1A21*F contains the -163C >A substitution and is highly inducible

CYP1A21*F contains the -163C>A substitution and is highly inducible

Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation

Red blood cell folate concentrations and polyglutamate distribution in juvenile arthritis